Kyntra Bio, Inc. (KYNB)

7.39 +0.31 (+4.38%) USD  |  NASDAQ  |  Apr 14, 15:59
More

Kyntra Bio EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for KYNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Anixa Biosciences, Inc. Upgrade
GT Biopharma, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Monte Rosa Therapeutics, Inc. Upgrade
Septerna, Inc. --